EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Biotechnology

EpiBone

Nina Tandon

Ph.D./Mba Nina Tandon

The Research and Development team at EpiBone is dedicated to innovating and refining the company's bone reconstruction technologies. This team conducts cutting-edge research on stem cell applications and tissue engineering to develop customized autologous-like bone grafts tailored to individual patients' needs. By collaborating closely on product development, experimentation, and laboratory processes, they aim to enhance the effectiveness and safety of bone grafts, ensuring superior outcomes for patients undergoing bone-related surgeries.

Research and Development

About

Team members

Other teams at EpiBone

Advisory and Strategic Consulting

Administrative Support